Related Experiment Video
Updated: Apr 29, 2026

Aggravation of Myocardial Ischemia upon Particulate Matter Exposure in Atherosclerosis Animal Model
Published on: December 10, 2021
β₂-Adrenergic agonists augment air pollution-induced IL-6 release and thrombosis
Abstract:
Acute exposure to particulate matter (PM) air pollution causes thrombotic cardiovascular events, leading to increased mortality rates; however, the link between PM and cardiovascular dysfunction is not completely understood. We have previously shown that the release of IL-6 from alveolar macrophages is required for a prothrombotic state and acceleration of thrombosis following exposure to PM. Here, we determined that PM exposure results in the systemic release of catecholamines, which engage the β2-adrenergic receptor (β2AR) on murine alveolar macrophages and augment the release of IL-6. In mice, β2AR signaling promoted the development of a prothrombotic state that was sufficient to accelerate arterial thrombosis. In primary human alveolar macrophages, administration of a β2AR agonist augmented IL-6 release, while the addition of a beta blocker inhibited PM-induced IL-6 release. Genetic loss or pharmacologic inhibition of the β2AR on murine alveolar macrophages attenuated PM-induced IL-6 release and prothrombotic state. Furthermore, exogenous β2AR agonist therapy further augmented these responses in alveolar macrophages through generation of mitochondrial ROS and subsequent increase of adenylyl cyclase activity. Together, these results link the activation of the sympathetic nervous system by β2AR signaling with metabolism, lung inflammation, and an enhanced susceptibility to thrombotic cardiovascular events.
Insights
Particulate matter (PM) air pollution triggers catecholamine release, activating beta-2 adrenergic receptors (β2AR) on macrophages. This enhances IL-6 release, promoting a prothrombotic state and increasing cardiovascular event risk.
Area of Science:
- Environmental Health
- Cardiovascular Research
- Immunology
Background:
- Particulate matter (PM) exposure is linked to thrombotic cardiovascular events and mortality.
- Interleukin-6 (IL-6) release from alveolar macrophages is crucial for PM-induced prothrombotic states.
- The precise mechanisms connecting PM exposure to cardiovascular dysfunction remain incompletely understood.
Purpose of the Study:
- To investigate the role of catecholamines and beta-2 adrenergic receptors (β2AR) in mediating PM-induced IL-6 release and prothrombotic effects.
- To elucidate the signaling pathways involved in β2AR activation in alveolar macrophages following PM exposure.
Main Methods:
- Murine models and primary human alveolar macrophages were used to assess IL-6 release and prothrombotic status.
- Experiments involved PM exposure, catecholamine administration, β2AR agonists/antagonists, and genetic manipulation of β2AR.
- Mitochondrial reactive oxygen species (ROS) generation and adenylyl cyclase activity were measured.
Main Results:
- PM exposure induced systemic catecholamine release, activating β2AR on murine alveolar macrophages and augmenting IL-6 release.
- β2AR signaling in mice promoted a prothrombotic state, accelerating arterial thrombosis.
- In human macrophages, β2AR agonists increased IL-6, while beta-blockers inhibited PM-induced IL-6 release.
- Genetic or pharmacologic β2AR inhibition attenuated PM-induced IL-6 and prothrombotic responses.
- β2AR agonists enhanced macrophage responses via mitochondrial ROS and increased adenylyl cyclase activity.
Conclusions:
- PM exposure activates the sympathetic nervous system through β2AR signaling on alveolar macrophages.
- This pathway links environmental pollution, inflammation, and metabolic changes to increased susceptibility to thrombotic cardiovascular events.
Related Concept Videos
Antiasthma Drugs: β2-Adrenoceptor Agonists
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
Adrenergic Agonists: Therapeutic Uses
Emergency and Intensive Care Unit (ICU) applications: Pressor agents increase blood pressure, heart rate, and contractility in shock and organ failure situations. Dopamine can induce vasodilation and stimulate adrenoceptors. Endogenous catecholamines are effective in treating cardiogenic shock. α2-agonists like clonidine can reverse anesthesia-induced hypertension.
Allergies and...
Adrenergic Antagonists: ɑ and β-Receptor Blockers
Antiasthma Drugs: Leukotriene Modifiers
Leukotriene modifiers work through two distinct mechanisms:
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Inflammation
Asthma-II: Pathophysiology and Classification
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:

